Enanta Pharmaceuticals Inc (ENTA)

[exwannabe]

FWIW I'm putting ABBV/ENTA at having around 8-10% of NRx market so far which seems pretty good to me only 4 weeks in. The NRx last week was 180 and that was without ESRX #s. I'd imagine there are an additional 150-300 Rx from ESRX (which are not being reported) which is how I arrive at that market share #. I guess we'll find out Friday!

Isn't the NRx number a bit biased this early? I assume these refill at either 4 weeks or a month, so ABBV's numbers will still be in the accumulation phase.

And with ESRX not counted, they become almost meaningless. Perhaps in a few Qs we can see how they track actual results.